Interested in a novel role for IL17 in tissue repair!? Check out this study out today in ⁦Science Magazine⁩ by ⁦Dr. Shruti Naik⁩ ⁦Piotr Konieczny⁩ Yue Xing and co on how IL17 drives HIF1a activation to promote wound healing. science.org/doi/10.1126/sc…

Visiting Leuven so many times (>6). I still live this beautiful building and the atmosphere😁

Join the program alongside David Tuveson Cold Spring Harbor Laboratory when he presents Addressing the seven hallmarks of #pancreatic #cancer this October Cell Symposia #CSHallmarks. Abstract deadline June 24. hubs.li/Q019zX6k0

💊🔬🧪La revue de littérature Inserm - #agenceANRS sur la #COVID19 est en ligne : 👉bit.ly/3BHja3C La veille sur les #hépatites aiguës d'origine inconnue chez les #enfants a aussi été mise à jour : 👉bit.ly/3FmC2s0

📢 Don't miss the opportunity to participate in one of the most important cancer conferences to be held in France this year ! #CancerResearch #CRCLSymposium #Cancerconference

Much of our knowledge of human health and disease is segmented based on medical specialty. Yale School of Medicine's Ruslan Medzhitov sees an opportunity to uncover broader patterns that contribute to health and disease. Yale Department of Immunobiology medicine.yale.edu/news/medicinea…

Want to discover why NK cells don’t work in cancer patients? We are looking for a talented postdoc to take on this challenge TCD Biochem & Immuno TCD TBSI Email me Clair Gardiner if you are interested. #NKcells #Immunometabolism #Cancer

HBV meeting 2022. Great discussions and presentations from molecular., immunology, and clinical scientist all aiming to find a functional cure. Highlighted by Fabien Zoulim ICE-HBV

Save the date: Innasco meeting very soon innasco.sciencesconf.org Inserm Auvergne-Rhône-Alpes @ENSdeLyon Inserm_EN CRCL Cook Inlet Region

I'm SO EXCITED to share our new pre-print! 🥳 You finally got your RNA-seq data. You open RStudio, stare at the screen for 5 mins...And realize you don't even remember how to import a table. How will you analyze your data?!😱We're here to help! A 🧵👇(1/9) biorxiv.org/content/10.110…

theguardian.com/society/2022/n…

Reducing #cancer mortality rates among the most disadvantaged groups is crucial to lowering the overall burden of cancer. We need action on the substantial #SocioeconomicInequalities that drive cancer mortality in #Europe. #SocialDeterminants #Inequality iarc.who.int/news-events/so…

It's out, the #IRCI2022 meeting summary. Well done to all the students and scientists for putting this together! CIRI Lyon CRCL @ENSdeLyon

Thanks E. John Wherry Bertoletti Lab Maini Lab UCL Ruslan Medzhitov Belkaid Lab IdoAmitLab @adrianhayday Lucie Etienne @Es_cheri_chia and all speakers at #IRCI2022 for their splendid talks.

"This isn't just a cancer therapy. This is a way of liberating people from the burden of having a disease that could come back and kill you." On #WorldCancerDay, our 2018 medicine laureates reflect on the hope their remarkable cancer therapy gives to patients around the globe.

Delighted to announce InnaSCo-FrontInov Symposium; September 5th- 7th 2023, Lyon. To share recent findings related to inflammasomes & IFN sensors in infection, cancer and autoinflammation registrations innasco.sciencesconf.org CIRI Lyon Inserm @ENSdeLyon CRCL CNRS 🌍

Great meeting. Thanking all organisers for this excellent focus and discussion with follow experts on cancer in the EU.

Fantastic annual #RNH2024 meeting of ANRS Maladies infectieuses émergentes , with nice presentation, including two from our team!!"

.@IARC_Dir Dr Elisabete Weiderpass & CIRI Lyon's Dr Uzma Hasan & Dr Thierry Walzer welcome UAR Biosciences 3444, CIRI Lyon & IARC researchers to a meeting at IARC, tomorrow, 9h-14 CEST, to foster collaboration & promote knowledge↔️among🧑‍🔬from local institutes iarc.who.int/news-events/ia…

See this Instagram video by immunomodel instagram.com/reel/DF6ZoKYoV…